Nath Bio-Genes (India) Limited
: NATHBIOGEN · Other Agricultural Products
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Nath Bio-Genes (India) Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Nath Bio-Genes (India) Ltd is an agri-tech company specialising in the research, production, and marketing of hybrid and genetically modified seeds. The company provides a diverse portfolio of BT, hybrid, and varietal seeds to farmers across India.
Business Model
The company generates revenue by developing and supplying high-quality seeds to the agricultural sector. It operates through a contract farming model, leasing land from growers and entering into production agreements to manage cultivation and processing costs.
- Incorporation Year:1993
Growth Outlook
Growth is driven by the continuous development of high-yield hybrid and GM seed varieties tailored for Indian climatic conditions. The company aims to expand its market reach by providing affordable, quality agricultural inputs to the farming community.
Key Risks
- Climatic Dependency. The company's performance is highly sensitive to unpredictable weather patterns and monsoon cycles which impact seed demand and production yields.
- Regulatory Risk. The seed industry is subject to stringent government regulations regarding GM technology, pricing controls, and intellectual property rights.
- Agricultural Commodity Price Volatility. Fluctuations in the market prices of agricultural produce can influence the purchasing power and investment decisions of the company's farmer customer base.
- Supply Chain Dependency. Reliance on third-party growers for seed production introduces risks related to quality control and consistency in output.
Start your research today
Unlock AI insights, financials, peers and live data on Nath Bio-Genes (India) Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹445 Cr
TTM · consolidated
NET PROFIT
₹42 Cr
TTM · consolidated
EPS
₹21.03
TTM · consolidated
RETURN ON EQUITY
6.4%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
10.8%
TTM · standalone
P/E
7.6x
Q4 FY26 · consolidated
EV/EBITDA
5.3x
Q4 FY26 · consolidated
EBITDA MARGIN
13.5%
TTM · consolidated
NET PROFIT MARGIN
0.0%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.2x
Q4 FY26 · consolidated
Peers · Other Agricultural Products
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Nath Bio-Genes (India) LimitedNATHBIOGEN | ₹299 Cr | 7.48 | 6.00 | 22.0% | 13.5% | 6.4% | 10.8% | -7.9% |
Regaal ResourcesREGAAL | ₹950 Cr | 15.27 | 11.12 | — | 12.3% | 12.2% | 12.0% | -18.9% |
Sukhjit Starch & Chemicals LimitedSUKHJITS | ₹497 Cr | 14.53 | 7.51 | -0.9% | 7.5% | 6.2% | 10.2% | -3.8% |
Mangalam Global Enterprise LimitedMGEL | ₹476 Cr | 10.03 | 8.41 | 41.4% | 2.3% | 19.0% | 34.2% | -11.6% |
Modi NaturalsMODINATUR | ₹463 Cr | 9.15 | 8.36 | 8.5% | 10.4% | 34.2% | 28.4% | -28.0% |
Sarveshwar FoodsSARVESHWAR | ₹419 Cr | 6.18 | 9.33 | 16.4% | 5.1% | 8.4% | 17.4% | -53.9% |
As of Q4 FY26
Financials
Nath Bio-Genes (India) Limited
: NATHBIOGEN · Other Agricultural Products
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Nath Bio-Genes (India) Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Nath Bio-Genes (India) Ltd is an agri-tech company specialising in the research, production, and marketing of hybrid and genetically modified seeds. The company provides a diverse portfolio of BT, hybrid, and varietal seeds to farmers across India.
Business Model
The company generates revenue by developing and supplying high-quality seeds to the agricultural sector. It operates through a contract farming model, leasing land from growers and entering into production agreements to manage cultivation and processing costs.
- Incorporation Year:1993
Growth Outlook
Growth is driven by the continuous development of high-yield hybrid and GM seed varieties tailored for Indian climatic conditions. The company aims to expand its market reach by providing affordable, quality agricultural inputs to the farming community.
Key Risks
- Climatic Dependency. The company's performance is highly sensitive to unpredictable weather patterns and monsoon cycles which impact seed demand and production yields.
- Regulatory Risk. The seed industry is subject to stringent government regulations regarding GM technology, pricing controls, and intellectual property rights.
- Agricultural Commodity Price Volatility. Fluctuations in the market prices of agricultural produce can influence the purchasing power and investment decisions of the company's farmer customer base.
- Supply Chain Dependency. Reliance on third-party growers for seed production introduces risks related to quality control and consistency in output.
Start your research today
Unlock AI insights, financials, peers and live data on Nath Bio-Genes (India) Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹445 Cr
TTM · consolidated
NET PROFIT
₹42 Cr
TTM · consolidated
EPS
₹21.03
TTM · consolidated
RETURN ON EQUITY
6.4%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
10.8%
TTM · standalone
P/E
7.6x
Q4 FY26 · consolidated
EV/EBITDA
5.3x
Q4 FY26 · consolidated
EBITDA MARGIN
13.5%
TTM · consolidated
NET PROFIT MARGIN
0.0%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.2x
Q4 FY26 · consolidated
Peers · Other Agricultural Products
As of Q4 FY26